PNC Financial Services Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-80
| Closed | -$71 | – | 4891 |
|
|
2022
Q4 | $71 | Sell |
80
-1,980
| -96% | -$1.76K | ﹤0.01% | 4713 |
|
|
2022
Q3 | $3K | Sell |
2,060
-16,000
| -89% | -$23.3K | ﹤0.01% | 4133 |
|
|
2022
Q2 | $36K | Buy |
18,060
+15,000
| +490% | +$29.9K | ﹤0.01% | 3194 |
|
|
2022
Q1 | $7K | Hold |
3,060
| – | – | ﹤0.01% | 3929 |
|
|
2021
Q4 | $14K | Sell |
3,060
-2,282
| -43% | -$10.4K | ﹤0.01% | 3693 |
|
|
2021
Q3 | $41K | Hold |
5,342
| – | – | ﹤0.01% | 3189 |
|
|
2021
Q2 | $51K | Buy |
5,342
+1,982
| +59% | +$18.9K | ﹤0.01% | 3063 |
|
|
2021
Q1 | $28K | Sell |
3,360
-1,564
| -32% | -$13K | ﹤0.01% | 3278 |
|
|
2020
Q4 | $34K | Sell |
4,924
-1,776
| -27% | -$12.3K | ﹤0.01% | 3129 |
|
|
2020
Q3 | $75K | Sell |
6,700
-24,201
| -78% | -$271K | ﹤0.01% | 2488 |
|
|
2020
Q2 | $194K | Buy |
+30,901
| New | +$194K | ﹤0.01% | 1951 |
|
|
2018
Q4 | – | Sell |
-4,500
| Closed | -$20K | – | 4231 |
|
|
2018
Q3 | $20K | Hold |
4,500
| – | – | ﹤0.01% | 3456 |
|
|
2018
Q2 | $32K | Hold |
4,500
| – | – | ﹤0.01% | 3266 |
|
|
2018
Q1 | $23K | Buy |
+4,500
| New | +$23K | ﹤0.01% | 3378 |
|
|
2017
Q2 | – | Sell |
-2,400
| Closed | -$9K | – | 4250 |
|
|
2017
Q1 | $9K | Hold |
2,400
| – | – | ﹤0.01% | 3585 |
|
|
2016
Q4 | $12K | Hold |
2,400
| – | – | ﹤0.01% | 3431 |
|
|
2016
Q3 | $19K | Hold |
2,400
| – | – | ﹤0.01% | 3256 |
|
|
2016
Q2 | $13K | Hold |
2,400
| – | – | ﹤0.01% | 3440 |
|
|
2016
Q1 | $13K | Hold |
2,400
| – | – | ﹤0.01% | 3467 |
|
|
2015
Q4 | $21K | Sell |
2,400
-74,261
| -97% | -$650K | ﹤0.01% | 3282 |
|
|
2015
Q3 | $643K | Buy |
+76,661
| New | +$643K | ﹤0.01% | 1422 |
|